The Liver Transplant Program at the UF Health Shands Transplant Center has more than twenty-two years of experience providing excellent care to patients with the most complex liver disease in the state of Florida. Our program features University of Florida physicians and multidisciplinary teams of specially trained coordinators, nurses, social workers, pharmacists, physical therapists and psychologists who are experts in transplant care.
The UF Health Shands Transplant Center at the University of Florida has performed a combined of more than 8,000 organ transplants since the first program began in 1966. The center performs transplants of the heart, lung, kidney, liver and pancreas. The patient population includes adults and children, and some patients receive multiple life-saving organ transplants at UF Health Shands Transplant Center.
Our multidisciplinary team of physicians, nurse coordinators, social workers and pharmacists provide lifelong compassionate care to our patients. Under the leadership of the Medical Director of Liver Transplant, Roniel Cabrera, M.D., M.S., the liver transplant program is providing hope to patients with end-stage liver disease by evaluating patients, adding patients to the wait list, and performing transplants.
- With great experience and a record for excellent outcomes, UF Health Shands Transplant Center is uniquely qualified to accept higher-risk candidates. Multiple specialty programs at UF Health are ranked by U.S. News and World Report each year.
- Team members lecture worldwide, are actively involved in transplant policy-making committees, and are nationally recognized for their contributions to clinical transplantation and research.
- Our team is committed to following patients throughout their lifetime, and UF Health Shands Transplant Center has patient data spanning decades.
If you are a patient, please call (352) 265-0754 with any questions or visit the UF Health Transplant Center.
- Transplant Hepatology Fellowship
Understand the importance of screening/surveillance of at risk patients with cirrhosis and the most effective surveillance strategies, that evaluation of HCC require a multidisciplinary team, and how to management both the HCC and cirrhosis aspect of these patients.